Contineum Therapeutics Stock (NASDAQ:CTNM), Quotes and News Summary

Q: What sector and industry does Contineum Therapeutics (CTNM) operate in?

Contineum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Contineum Therapeutics Stock (NASDAQ: CTNM) stock price, news, charts, stock research, profile.

Open	$15.760
Close	-
Volume / Avg.	4.429K / 171.532K
Day Range	15.760 - 16.000
52 Wk Range	13.900 - 16.060
Market Cap	$402.595M
P/E Ratio	14.170
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	-
Days to Cover	-

Recent News

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.

Avi Kapoor

UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Contineum Therapeutics (CTNM) stock?

You can purchase shares of Contineum Therapeutics (NASDAQ: CTNM) through any online brokerage.

View our list of the best stock brokerages.

Who are Contineum Therapeutics's (CTNM) competitors?

Other companies in Contineum Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).

What is the target price for Contineum Therapeutics (CTNM) stock?

The latest price target for Contineum Therapeutics (NASDAQ: CTNM) was reported by Stifel on Tuesday, April 30, 2024. The analyst firm set a price target for 29.00 expecting CTNM to rise to within 12 months (a possible 81.25% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Contineum Therapeutics (CTNM)?

The stock price for Contineum Therapeutics (NASDAQ: CTNM) is $16 last updated Today at May 1, 2024 at 10:26 AM EDT.

Does Contineum Therapeutics (CTNM) pay a dividend?

There are no upcoming dividends for Contineum Therapeutics.

When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?

Contineum Therapeutics’s Q2 earnings are confirmed for Thursday, May 16, 2024.

Is Contineum Therapeutics (CTNM) going to split?

There is no upcoming split for Contineum Therapeutics.

What sector and industry does Contineum Therapeutics (CTNM) operate in?

Contineum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-